Yaohai has been wanted to share with you some new and important information about a unique pharmaceutical product — recombinant midkine. This is a very special product built to get people out of their sickbeds and to improve healthcare for all. And that is why we are so excited about the prospects of recombinant midkine in patients around the world.
Biotechnology is an interesting area, which involves the blend of technology and science. It helps craft the new that might built a better world. At its most basic, it is the use of biology to make health, food and environment better. The Rekombinant insulinanalog biotillverkning future of biotech is at a very exciting place, and we are so happy to be part of this change. It is based on finding intelligent and efficient ways to produce recombinant midkine through biotechnology which will allow the development of new remedies for the well-being of many diseased or suffering individuals.
Midkine is a unique protein that occurs naturally in the human body. JI Development — It is necessary for the growth and development of tissues and organs of our body. Recombinant DNA technology is a process used by scientists to produce midkine in the laboratory. This Rekombinant insulintillverkning leads to the production of a cleaner and more potent form of midkine used against various disorders.
We are also highly passionate about our recombinant midkine in Yaohai and hoping that there may be found more cute ways to environmental problems. With the most current technology and tested tools via our labs, we can deliver only to the highest safety, and quality requirements. We know that when we produce our products, its peoples and planets need to help them.
Midkine Expression and Recombinant Midkine Have the Potential to be a Very Important for Medicine Numerous studies have shown that it can help us in many ways, even with major illnesses like cancer, inflammation plus it can aid nerves heal after the injury. This Rekombinant Insulin Mutation Biotillverkning new technology is exciting to many doctors and scientists because it could lead to improved and targeted therapies for these important disorders and others.
Yaohai is making great efforts to find out how recombinant midkine can benefit patients. Our team of experts continuously explore all the new ways this unique protein can benefit people's lives and help in their recovery. Our Rekombinant svininsulin biotillverkning commitment is to ensure our product is the best it can be and gives the most patient benefit possible.
Recombinant midkine is a version of the protein that has been produced in the lab using recombinant DNA technology, and its characterization starts with our scientists. The research team starts with determining what makes the midkine protein. The group identifies and secluded the midkine gene -- that portion of DNA which says to our cells: "This is how you make the important protein". From here, they gently place this gene into a bacterial cell. The GMP Rekombinant Peptide Manufacturing bacteria grow and replicate, creating lots of midkine protein. As this is a complex process, there are several quality controls taken to guarantee that everything is happening right and safe.
Yaohai Bio-Pharma, a Recombinant Midkine Manufacturing manufacturer of biological products, is a specialist in microbial fermentations. We have built a modern factory equipped with modern facilities and strong RD and manufacturing capabilities. Five drug substance production lines that are compliant with GMP standards for microbial purification and ferment, as well as two fill and finish lines for vials as well as cartridges, as well as needles that are pre-filled, are readily available. The available fermentation scales vary from 100L to 500L, 1000L, to 2000L. Filling volumes vary from 1ml to 25ml. Syringes or cartridges pre-filled are filled with the equivalent of 1-3ml. Our cGMP-compliant production facility ensures the availability of stable clinical samples and commercial products. The big molecules that are produced at our plant are readily available for international delivery.
Yaohai Bio-Pharma, a leader in Recombinant Midkine Manufacturing of microbial biologics, is located in Jiangsu. We are focusing on microbially produced therapeutics and vaccines that are suited for human, veterinary, and pet health management. We have modern RD as well as manufacturing technology platforms that cover the entire process, from engineering microbial strains, cell banking, process and method development, through to commercial and clinical manufacturing, making sure that we can ensure the successful supply of the most cutting-edge solutions. We have acquired a large amount of experience in the microbial bio processing field. More than 200 projects have been completed successfully and we support our clients in overcome regulations such as those of the US FDA and EU EMA. We also aid them with Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services thanks to our experience and expertise.
Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Recombinant Midkine Manufacturing, Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.
Yaohai Bio-Pharma is experienced in biologicals derived from microbial sources. We provide customized RD solutions and manufacturing, while minimising potential risks. We have worked on various modalities, including recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies enzymes, plasmid DNA various mRNAs, and more. We have specialized in multiple microorganisms, including Recombinant Midkine Manufacturing intracellular and extracellular secretion (yields up to 15g/L) and intracellular soluble bacteria and inclusion body (yields up to 10g/L). We have also established a BSL-2 fermentation platform to create bacteria-based vaccines. We are experts in improving processes, boosting product yields, and decreasing production costs. We have a highly efficient technology team that ensures timely and top-quality project delivery. This allows us to bring your unique products faster to market.